` Comparison: IPD, ABT - Alpha Spread

IPD
vs
ABT

Over the past 12 months, IPD has underperformed ABT, delivering a return of -31% compared to the ABT's +9% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
IPD
ABT
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

IPD Intrinsic Value
0.085 AUD
Undervaluation 59%
Intrinsic Value
Price
ABT Intrinsic Value
114.3 USD
Overvaluation 8%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
ImpediMed Ltd
ASX:IPD
0.035 AUD
Abbott Laboratories
NYSE:ABT
124.85 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
IPD, ABT

IPD
ABT
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
ImpediMed Ltd
Revenue
Abbott Laboratories
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
IPD, ABT

IPD
ABT
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
ImpediMed Ltd
ASX:IPD
Abbott Laboratories
NYSE:ABT
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

IPD
86.3%
ABT
56.2%
LTM 3Y Avg 5Y Avg 10Y Avg
ImpediMed Ltd
Abbott Laboratories

Operating Margin

IPD
-180.8%
ABT
18.3%
LTM 3Y Avg 5Y Avg 10Y Avg
ImpediMed Ltd
Abbott Laboratories

Net Margin

IPD
-182.6%
ABT
31.9%
LTM 3Y Avg 5Y Avg 10Y Avg
ImpediMed Ltd
Abbott Laboratories

FCF Margin

IPD
-122.9%
ABT
15.8%
LTM 3Y Avg 5Y Avg 10Y Avg
ImpediMed Ltd
Abbott Laboratories

ROE

IPD
-75.9%
ABT
30.8%
LTM 3Y Avg 5Y Avg 10Y Avg
ImpediMed Ltd
Abbott Laboratories

ROA

IPD
-52.4%
ABT
17.6%
LTM 3Y Avg 5Y Avg 10Y Avg
ImpediMed Ltd
Abbott Laboratories

ROIC

IPD
-119.1%
ABT
20.4%
LTM 3Y Avg 5Y Avg 10Y Avg
ImpediMed Ltd
Abbott Laboratories

ROCE

IPD
-58.8%
ABT
12.4%
LTM 3Y Avg 5Y Avg 10Y Avg
ImpediMed Ltd
Abbott Laboratories

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
IPD, ABT

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IPD, ABT

Loading
IPD
ABT
Difference
www.alphaspread.com

Performance By Year
IPD, ABT

Loading
IPD
ABT
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare IPD to other stocks
Unlock Full Access to Alpha Spread
Create Free Account